Western Blotting Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, Application, End User, and Region: Global Opportunity Analysis and Industry Forecast, 2024-2033

The western blotting market was valued at $1,009.40 million in 2023 and is estimated to reach $1,736.98 million by 2033, exhibiting a CAGR of 6.0% from 2024 to 2033.

Market Definition and Overview

Western blotting, also known as immunoblotting, is a powerful laboratory technique used to detect specific proteins in a complex mixture of proteins extracted from cells or tissues. It involves the separation of proteins by gel electrophoresis based on their size and charge, followed by transfer to a solid membrane and detection using antibodies that bind to the target protein. This technique is fundamental in molecular biology and biomedical research for studying protein expression, post-translational modifications, and protein-protein interactions.

Western blotting plays a crucial role in various areas such as cancer research, infectious diseases, neuroscience, and drug development. Researchers use Western blotting to identify disease biomarkers, validate drug targets, and understand signaling pathways. Despite its complexity and time-consuming nature, western blotting offers high sensitivity and specificity, making it indispensable in protein analysis. Continuous advancements in technology are improving the efficiency and reproducibility of western blotting, further expanding its applications in both basic research and clinical diagnostics, thus contributing significantly to advancements in understanding disease mechanisms and developing new therapeutic strategies.

Key Takeaways

• The western blotting market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($million) for the projected period from 2024 to 2033.
• More than 1,500 product literatures, industry releases, annual reports, and other such documents of major western blotting industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
• The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.

Industry Trends

• According to data from October 2022 released by the U.S. Department of Health & Human Services, an estimated 1.2 million individuals in the U.S. are living with HIV, with approximately 13% of them unaware of their HIV status and requiring testing. This highlights the crucial role of western blotting in detecting infectious diseases like HIV and highlights the increasing demand for accurate diagnostic tools in healthcare systems globally.
• In January 2021, Bio-Rad Laboratories, a global leader in life science research and clinical diagnostic products, announced the launch of the Bio-Rad Western Blotting Learning Center. This online library offers comprehensive resources, information, and guidance to assist researchers in enhancing their western blotting (or immunoblotting) techniques for obtaining high-quality data.

Key Market Dynamics

Western blotting techniques are increasingly vital in molecular biology research, particularly in protein analysis and characterization, a trend expected to drive market expansion. The rising adoption of western blotting in biomedical and biotechnological research, drug discovery, and personalized medicine further boosts market growth. In addition, the increasing prevalence of chronic diseases contributes significantly to the expansion of the western blotting market. Chronic conditions like cancer, cardiovascular disorders, and neurological diseases are on the rise globally. Western blotting plays a key role in the diagnosis, prognosis, and therapeutic development of these diseases. Owing to the rising patient population affected by chronic illnesses, the demand for western blotting techniques in disease management is expected to increase, thereby stimulating market growth in the upcoming years.

Technical limitations and complexity restrain the western blotting market growth. Western blotting involves multiple steps including gel electrophoresis, protein transfer, blocking, antibody incubation, and detection. Each step requires precision and can be time-consuming. Performing western blotting accurately requires expertise and training. Complexity of the technique can limit its adoption in laboratories with limited expertise.

The development and adoption of automated western blotting systems can enhance efficiency, reduce human error, and save time, making them attractive to laboratories and research institutions. Western blotting allows for the detection of specific protein biomarkers, crucial for patient stratification, treatment monitoring, and assessing drug efficacy. Its role in identifying unique protein expression patterns in individuals drives research and diagnostic applications, creating opportunities for advanced, patient-specific treatments. Consequently, the demand for western blotting technologies and services increases as personalized medicine continues to gain prominence in healthcare.

Patent of Global Western Blotting Market

AMOLIFESCIENCE CO., LTD. has developed an innovative composite membrane for western blotting, which has been registered with the U.S. Patent and Trademark Office. The application details are published as of May 16, 2024. This new composite membrane is created by integrating nanofiber webs with nonwoven fabrics, presenting a range of significant advantages.

The nanofiber component of the membrane has a basis weight ranging from 1 gsm to 50 gsm, applied onto the nonwoven fabrics. Moreover, the average pore size of these nanofibers falls between 0.1 μm and 1.0 μm. This specific structure of the composite membrane, which incorporates nanofibers, not only reduces production costs but also enhances the membrane’s response characteristics due to the capillary effects produced by its double-layered structure.

These unique features make the composite membrane particularly effective in western blotting applications, allowing for the easy detection of even trace amounts of specific substances present in proteins. This advancement represents a significant improvement in the efficiency and cost-effectiveness of protein detection methodologies.

Market Segmentation

The western blotting market is segmented into product, application, end user, and region. On the basis of product, the market is divided into instruments and consumables. On the basis of application, the market is classified into biomedical & biochemical research, disease diagnostics, and others. On the basis of end user, the market is divided into academia & research institutes, diagnostic centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Country Market Outlook

The rapid growth of the biotechnology and pharmaceutical sectors in countries such as China, India, and Japan has significantly boosted the western blotting market. Increased R&D activities in these industries necessitate the use of advanced protein detection methods. Technological advancements in western blotting techniques, such as the development of automated systems and improvements in imaging and detection methods, are notable trends. These advancements enhance the accuracy and efficiency of the technique, making it more accessible and user-friendly for researchers.

• In September 2021, the Chinese government announced a significant increase in funding for biomedical research as part of its Five-Year Plan. This initiative included specific grants for projects utilizing advanced techniques such as western blotting, aiming to foster innovation and improve healthcare outcomes.

Competitive Landscape

The major players operating in the western blotting market include Merck & Co., Inc, F. Hoffmann-La Roche Ltd., GE Healthcare, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation (Cytiva), PerkinElmer, Inc., Emagin Corporation., Cell Signaling Technology, DANAHER, and others.

Recent Key Strategies and Developments

• In August 2021, Abcam Plc acquired BioVision Inc., a U.S.-based company known for its global supply of life science research tools used in research, diagnostics, and drug discovery. BioVision is a UK-based leading provider of biochemical and cell-based assays, as well as a wide range of products like recombinant proteins, antibodies, enzymes, and biochemical compounds essential for immunoassay technologies such as western blotting.
• In April 2021, Bio-Techne Corporation (U.S.) introduced Abby, a next-generation chemiluminescence system designed to automate traditional western blotting.

Key Sources Referred

1. Company Annual Reports
2. Investor Presentations
3. Press Release
4. Research Paper
5. D&B Hoovers
6. ZoomInfo Technologies LLC
7. ocw.nagoya
8. National Institutes of Health (NIH) (.gov)
9. Boston University
10. ScienceDirect

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the western blotting market segments, current trends, estimations, and dynamics of the western blotting market analysis from 2023 to 2033 to identify the western blotting market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the western blotting market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global western blotting market statistics.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

Apart from the points mentioned above, the report includes the analysis of the regional as well as western blotting market trends, key players, market segments, application areas, and market growth strategies.

1. Research Methodology

1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation

1.5.1. Top-down approach
1.5.2. Bottom-up approach

2. Report Scope

2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on global Western Blotting Market     

3. Executive Summary
4. Market Overview

4.1. Introduction
4.2. Growth impact forces

4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities

4.3. Market value chain analysis

4.3.1. List of raw material suppliers
4.3.2. List of manufacturers 
4.3.3. List of distributors

4.4. Innovation & sustainability matrices

4.4.1. Technology matrix
4.4.2. Regulatory matrix

4.5. Porter’s five forces analysis

4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity

4.6. PESTLE analysis

4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Legal
4.6.6. Environmental

4.7. Impact of COVID-19 on Western Blotting Market     

4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario

5. Western Blotting Market Analysis, by Product

5.1. Overview
5.2. Instruments

5.2.1. Definition, key trends, growth factors, and opportunities
5.2.2. Market size analysis, by region, 2023-2033
5.2.3. Market share analysis, by country, 2023-2033

5.3. Consumables

5.3.1. Definition, key trends, growth factors, and opportunities
5.3.2. Market size analysis, by region, 2023-2033
5.3.3. Market share analysis, by country, 2023-2033

5.4. Research Dive Exclusive Insights

5.4.1. Market attractiveness
5.4.2. Competition heatmap

6. Western Blotting Market Analysis, by Application 

6.1. Overview
6.2. Biomedical & Biochemical Research   

6.2.1. Definition, key trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2023-2033
6.2.3. Market share analysis, by country, 2023-2033

6.3. Disease Diagnostics

6.3.1. Definition, key trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2023-2033
6.3.3. Market share analysis, by country, 2023-2033

6.4. Others

6.4.1. Definition, key trends, growth factors, and opportunities
6.4.2. Market size analysis, by region, 2023-2033
6.4.3. Market share analysis, by country, 2023-2033

6.5. Research Dive Exclusive Insights

6.5.1. Market attractiveness
6.5.2. Competition heatmap

7. Western Blotting Market Analysis, by Application 

7.1. Overview
7.2. Academia & Research Institutes   

7.2.1. Definition, key trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2023-2033
7.2.3. Market share analysis, by country, 2023-2033

7.3. Disease Diagnostics

7.3.1. Definition, key trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2023-2033
7.3.3. Market share analysis, by country, 2023-2033

7.4. Others

7.4.1. Definition, key trends, growth factors, and opportunities
7.4.2. Market size analysis, by region, 2023-2033
7.4.3. Market share analysis, by country, 2023-2033

7.5. Research Dive Exclusive Insights

7.5.1. Market attractiveness
7.5.2. Competition heatmap

8. Western Blotting Market, by Region

8.1. North America

8.1.1. U.S.

8.1.1.1. Market size analysis, by Product, 2023-2033
8.1.1.2. Market size analysis, by Application, 2023-2033
8.1.1.3. Market size analysis, by End User, 2023-2033

8.1.2. Canada

8.1.2.1. Market size analysis, by Product, 2023-2033
8.1.2.2. Market size analysis, by Application, 2023-2033
8.1.2.3. Market size analysis, by End User, 2023-2033

8.1.3. Mexico

8.1.3.1. Market size analysis, by Product, 2023-2033
8.1.3.2. Market size analysis, by Application, 2023-2033
8.1.3.3. Market size analysis, by End User, 2023-2033

8.1.4. Research Dive Exclusive Insights

8.1.4.1. Market attractiveness
8.1.4.2. Competition heatmap

8.2. Europe

8.2.1. Germany 

8.2.1.1. Market size analysis, by Product, 2023-2033
8.2.1.2. Market size analysis, by Application, 2023-2033
8.2.1.3. Market size analysis, by End User, 2023-2033

8.2.2. UK

8.2.2.1. Market size analysis, by Product, 2023-2033
8.2.2.2. Market size analysis, by Application, 2023-2033
8.2.2.3. Market size analysis, by End User, 2023-2033

8.2.3. France

8.2.3.1. Market size analysis, by Product, 2023-2033
8.2.3.2. Market size analysis, by Application, 2023-2033
8.2.3.3. Market size analysis, by End User, 2023-2033

8.2.4. Spain

8.2.4.1. Market size analysis, by Product, 2023-2033
8.2.4.2. Market size analysis, by Application, 2023-2033
8.2.4.3. Market size analysis, by End User, 2023-2033

8.2.5. Italy

8.2.5.1. Market size analysis, by Product, 2023-2033
8.2.5.2. Market size analysis, by Application, 2023-2033
8.2.5.3. Market size analysis, by End User, 2023-2033

8.2.6. Rest of Europe

8.2.6.1. Market size analysis, by Product, 2023-2033
8.2.6.2. Market size analysis, by Application, 2023-2033
8.2.6.3. Market size analysis, by End User, 2023-2033

8.2.7. Research Dive Exclusive Insights

8.2.7.1. Market attractiveness
8.2.7.2. Competition heatmap

8.3. Asia-Pacific

8.3.1. China

8.3.1.1. Market size analysis, by Product, 2023-2033
8.3.1.2. Market size analysis, by Application, 2023-2033
8.3.1.3. Market size analysis, by End User, 2023-2033

8.3.2. Japan 

8.3.2.1. Market size analysis, by Product, 2023-2033
8.3.2.2. Market size analysis, by Application, 2023-2033
8.3.2.3. Market size analysis, by End User, 2023-2033

8.3.3. India

8.3.3.1. Market size analysis, by Product, 2023-2033
8.3.3.2. Market size analysis, by Application, 2023-2033
8.3.3.3. Market size analysis, by End User, 2023-2033

8.3.4. Australia

8.3.4.1. Market size analysis, by Product, 2023-2033
8.3.4.2. Market size analysis, by Application, 2023-2033
8.3.4.3. Market size analysis, by End User, 2023-2033

8.3.5. South Korea

8.3.5.1. Market size analysis, by Product, 2023-2033
8.3.5.2. Market size analysis, by Application, 2023-2033
8.3.5.3. Market size analysis, by End User, 2023-2033

8.3.6. Rest of Asia-Pacific

8.3.6.1. Market size analysis, by Product, 2023-2033
8.3.6.2. Market size analysis, by Application, 2023-2033
8.3.6.3. Market size analysis, by End User, 2023-2033

8.3.7. Research Dive Exclusive Insights

8.3.7.1. Market attractiveness
8.3.7.2. Competition heatmap

8.4. LAMEA

8.4.1. Brazil

8.4.1.1. Market size analysis, by Product, 2023-2033
8.4.1.2. Market size analysis, by Application, 2023-2033
8.4.1.3. Market size analysis, by End User, 2023-2033

8.4.2. Saudi Arabia

8.4.2.1. Market size analysis, by Product, 2023-2033
8.4.2.2. Market size analysis, by Application, 2023-2033
8.4.2.3. Market size analysis, by End User, 2023-2033

8.4.3. UAE

8.4.3.1. Market size analysis, by Product, 2023-2033
8.4.3.2. Market size analysis, by Application, 2023-2033
8.4.3.3. Market size analysis, by End User, 2023-2033

8.4.4. South Africa

8.4.4.1. Market size analysis, by Product, 2023-2033
8.4.4.2. Market size analysis, by Application, 2023-2033
8.4.4.3. Market size analysis, by End User, 2023-2033

8.4.5. Rest of LAMEA

8.4.5.1. Market size analysis, by Product, 2023-2033
8.4.5.2. Market size analysis, by Application, 2023-2033
8.4.5.3. Market size analysis, by End User, 2023-2033

8.4.6. Research Dive Exclusive Insights

8.4.6.1. Market attractiveness
8.4.6.2. Competition heatmap

9. Competitive Landscape

9.1. Top winning strategies, 2022

9.1.1. By strategy
9.1.2. By year

9.2. Strategic overview
9.3. Market share analysis, 2023

10. Company Profiles

10.1. Merck & Co., Inc
10.1.1. Overview
10.1.2. Business segments
10.1.3. Product portfolio
10.1.4. Financial performance
10.1.5. Recent developments
10.1.6. SWOT analysis

10.2. F. Hoffmann-La Roche Ltd.

10.2.1. Overview
10.2.2. Business segments
10.2.3. Product portfolio
10.2.4. Financial performance
10.2.5. Recent developments
10.2.6. SWOT analysis

10.3. GE Healthcare

10.3.1. Overview
10.3.2. Business segments
10.3.3. Product portfolio
10.3.4. Financial performance
10.3.5. Recent developments
10.3.6. SWOT analysis

10.4. Thermo Fisher Scientific, Inc.

10.4.1. Overview
10.4.2. Business segments
10.4.3. Product portfolio
10.4.4. Financial performance
10.4.5. Recent developments
10.4.6. SWOT analysis

10.5. Bio-Rad Laboratories, Inc.

10.5.1. Overview
10.5.2. Business segments
10.5.3. Product portfolio
10.5.4. Financial performance
10.5.5. Recent developments
10.5.6. SWOT analysis

10.6. Danaher Corporation (Cytiva)

10.6.1. Overview
10.6.2. Business segments
10.6.3. Product portfolio
10.6.4. Financial performance
10.6.5. Recent developments
10.6.6. SWOT analysis

10.7. PerkinElmer, Inc.

10.7.1. Overview
10.7.2. Business segments
10.7.3. Product portfolio
10.7.4. Financial performance
10.7.5. Recent developments
10.7.6. SWOT analysis

10.8. Emagin Corporation

10.8.1. Overview
10.8.2. Business segments
10.8.3. Product portfolio
10.8.4. Financial performance
10.8.5. Recent developments
10.8.6. SWOT analysis

10.9. Cell Signaling Technology

10.9.1. Overview
10.9.2. Busiess segments
10.9.3. Product portfolio
10.9.4. Financial performance
10.9.5. Recent developments
10.9.6. SWOT analysis

10.10. DANAHER.
10.10.1. Overview
10.10.2. Business segments
10.10.3. Product portfolio
10.10.4. Financial performance
10.10.5. Recent developments
10.10.6. SWOT analysis
 

* Taxes/Fees, If applicable will be added during checkout. All prices in USD.